HGEN - Humanigen, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
3,330
2,514
3,595
312
0
Operating expenses
Research development
91,945
55,210
213,115
72,713
2,616
Selling general and administrative
16,331
15,608
23,252
15,797
6,328
Total operating expenses
108,276
70,818
236,367
88,510
8,944
Operating income or loss
-104,946
-68,304
-232,772
-88,198
-8,944
Interest expense
3,548
2,918
2,264
1,336
1,349
Total other income/expenses net
-166
492
-1,613
-1
-1
Income before tax
-108,660
-70,730
-236,649
-89,535
-10,294
Income from continuing operations
-108,660
-70,730
-236,649
-89,535
-10,294
Net income
-108,660
-70,730
-236,649
-89,535
-10,294
Net income available to common shareholders
-108,660
-70,730
-236,649
-89,535
-10,294
Basic EPS
-
-
-4.04
-2.42
-0.46
Diluted EPS
-
-
-4.04
-2.42
-0.46
Basic average shares
-
-
58,534
36,963
22,361
Diluted average shares
-
-
58,534
36,963
22,361
EBITDA
-
-67,812
-234,385
-88,199
-8,945